• Home
  • News
  • Formula One has extended its partnership with Foxtel Group

Formula One has extended its partnership with Foxtel Group


Formula One has announced a contract extension with Foxtel Group. The multi-year agreement signed between the two parties is reportedly worth between $29.9 million and $33.6 million annually.

Formula One tie up with Foxtel Group

From the Beginning of 2023, Formula One’s over-the-top service will be integrated into Foxtel’s set-top box free of cost. This move materializing would benefit the fans as they would be able to enjoy watching additional content which includes watching live feeds and special supportive content.

Foxtel subscribers would be able to tune into the F1TV app which would provide multiple live in race feeds, comprehensive live timing data, session highlights, and exclusive programming from on and off the track. The fans would be able to watch live coverage of the event on Fox Sports and on Kayo the streaming platform.

Learn more about the exclusive content partnership announced between NBA and Formula One

“We’re delighted to be extending and expanding our partnership with the Foxtel Group so that our fans in Australia can continue to enjoy comprehensive Formula One coverage, and the integration of the F1TV app for subscribers will provide even more access to the sport than ever before. Foxtel is a great partner for Formula One, as we share the same passion to innovate and deliver spectacular racing to our fanbase”. Ian Holmes, Director of Media Rights and Content Creation Formula1.

“This new partnership with Formula One takes our coverage to the next level for fans”. “It’s a great story for Foxtel as the integration of the F1TV app into the Foxtel set-top boxes offers subscribers even more access to all the F1 action they love.” Patrick Delany, Foxtel Group CEO.

The announcement of this deal comes at a time when the country will host its very own Grand Prix in April. This event had been absent from the Formula One calendar for the last two years due to Covid-19.